EICHORCondition: Atrial Fibrillation · Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
The DISRUPT-AF Registry is an observational, prospective, multi-center, non-randomized, real-world registry designed to obtain clinical experience with the Farapulse Pulsed Field Ablation System for the treatment of atrial fibrillation (AF).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Arrhythmia Institute at Grandview | Birmingham, Alabama, United States | — |
| Arrhythmia Research Group | Jonesboro, Arkansas, United States | — |
| Sutter Health - California Pacific Medical Center | San Francisco, California, United States | — |
| Community Memorial Health Systems | Ventura, California, United States | — |
| South Denver Cardiology Associates | Littleton, Colorado, United States | — |
| The Arrythmia Center of South Florida | Delray Beach, Florida, United States | — |
| Ascension St. Vincent's | Jacksonville, Florida, United States | — |
| HCA Florida Mercy Hospital | Miami, Florida, United States | — |
| Sarasota Memorial Hospital | Sarasota, Florida, United States | — |
| St. Luke's Medical Center | Boise, Idaho, United States | — |
| Endeavor Health (Northshore) | Glenview, Illinois, United States | — |
| Ascension St Vincent -Indianapolis Ascension Health | Indianapolis, Indiana, United States | — |
+ 23 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06335082